Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …

Background The COVID-19 pandemic has affected the world deeply, with more than
14,000,000 people infected and nearly 600,000 deaths. This review aimed to summarize the …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Background High rate of cardiovascular disease (CVD) have been reported among patients
with novel coronavirus disease (COVID-19). Meanwhile there were controversies among …

Abstract Objectives The Janus kinase (JAK) inhibitor baricitinib may block viral entry into
pneumocytes and prevent cytokine storm in patients with SARS-CoV-2 pneumonia. We …

There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Objective To describe the characteristics and prognosis of patients with COPD admitted to
the hospital due to SARS-CoV-2 infection. Methods The SEMI-COVID registry is an ongoing …

Introducción Existen pocos estudios sobre pacientes con insuficiencia cardíaca (IC)
ingresados por COVID-19. Nuestro objetivo fue describir las características clínicas de los …

Antecedentes y objetivo La pandemia por SARS-CoV-2 condiciona elevadas tasas de
mortalidad en pacientes mayores hospitalizados. Actualmente, pocos estudios incluyen …

Introduction Spain is one of the countries with the highest number of COVID-19 patients.
Unfortunately, few data for regions are available. Objectives This study aimed to describe …